Your browser doesn't support javascript.
loading
Clinical research progress on ß-cell dysfunction in T2DM development in the Chinese population.
Chen, Yibing; Jiang, Qian; Xing, Xiaowei; Yuan, Tao; Li, Pingping.
Afiliação
  • Chen Y; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
  • Jiang Q; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China.
  • Xing X; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China.
  • Yuan T; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
  • Li P; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China.
Article em En | MEDLINE | ID: mdl-39382753
ABSTRACT
The prevalence of type-2 diabetes mellitus (T2DM) has increased over 10-fold in the past 40 years in China, which now has the largest T2DM population in the world. Insulin resistance and ß-cell dysfunction are the typical features of T2DM. Although both factors play a role, decreased ß-cell function and ß-cell mass are the predominant factors for progression to T2DM. Considering the differences between Chinese T2DM patients and those of other ethnicities, it is important to characterize ß-cell dysfunction in Chinese patients during T2DM progression. Herein, we reviewed the studies on the relationships between ß-cell function and T2DM progression in the Chinese population and discussed the differences among individuals of varying ethnicities. Meanwhile, we summarized the risk factors and current treatments of T2DM in Chinese individuals and discussed their impacts on ß-cell function with the hope of identifying a better T2DM therapy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rev Endocr Metab Disord / Rev. endocr. metab. disord / Reviews in endocrine & metabolic disorders Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rev Endocr Metab Disord / Rev. endocr. metab. disord / Reviews in endocrine & metabolic disorders Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha